News & Analysis as of

Regulatory Agenda › Innovation › Compliance

Ropes & Gray LLP

[Podcast] R&G Tech Studio: AI Innovation vs. Safety—Insights on a New Executive Order

Ropes & Gray LLP on

On this episode of the R&G Tech Studio podcast, Ropes & Gray partners and co-leaders of the firm’s AI initiative, Megan Baca and Ed McNicholas, delve into the key implications of President Trump’s new AI Executive Order...more

Fox Rothschild LLP

Could We Ditch the EU AI Act?

Fox Rothschild LLP on

Is the EU AI Act a Jenga piece that can easily be removed from the regulatory tower? Here are some key points from the “AI Regulation – a critical comment” workshop at the Alpine Privacy Days Conference, courtesy of Florent...more

NAVEX

The Evolving AI Regulatory Landscape in Asia: What Compliance Leaders Need to Know

NAVEX on

Artificial intelligence (AI) is transforming industries at an unprecedented pace, but it also introduces complex compliance challenges. While many regions are ramping up their regulatory frameworks to address these risks,...more

King & Spalding

EU AI Office Announces Organizational Structure & Hosts First Webinar

King & Spalding on

Last month the European Commission (“EC”) announced organizational details regarding the recently formed EU AI Office. Initially launched in January 2024 through the EC’s AI innovation package, the EU AI Office (“AI Office”)...more

White & Case LLP

AI Watch: Global regulatory tracker - United Nations

White & Case LLP on

Artificial intelligence (AI) has made enormous strides in recent years and has increasingly moved into the public consciousness. Increases in computational power, coupled with advances in machine learning, have fueled the...more

Smart & Biggar

Update on biosimilars in Canada – March 2024

Smart & Biggar on

In this article, we provide a further update on developments regarding biosimilars in Canada (approvals, pending submissions, litigation, regulatory, and market access) since our March 2023 update....more

Holland & Knight LLP

New Artificial Intelligence Executive Order Contains Numerous Healthcare Implications

Holland & Knight LLP on

President Joe Biden on Oct. 30, 2023, signed a sweeping executive order (EO) and invoked the Defense Production Act to establish the first set of standards for using artificial intelligence (AI) in healthcare and other...more

7 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide